{"id":1924,"date":"2023-11-29T10:00:45","date_gmt":"2023-11-29T01:00:45","guid":{"rendered":"https:\/\/prismbiolab.com\/?post_type=news&#038;p=1924"},"modified":"2024-04-10T18:18:55","modified_gmt":"2024-04-10T09:18:55","slug":"prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target","status":"publish","type":"news","link":"https:\/\/prismbiolab.com\/ja\/news\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\/","title":{"rendered":"PRISM BioLab\u3001\u7c73\u56fd\u88fd\u85ac\u5927\u624b\u30a4\u30fc\u30e9\u30a4\u30ea\u30ea\u30fc\u30fb\u30a2\u30f3\u30c9\u30fb\u30ab\u30f3\u30d1\u30cb\u30fc\u3068\u30e9\u30a4\u30bb\u30f3\u30b9\u304a\u3088\u3073\u5171\u540c\u7814\u7a76\u5951\u7d04\u3092\u7de0\u7d50"},"content":{"rendered":"<p>\u682a\u5f0f\u4f1a\u793ePRISM BioLab\u306f\u3001Eli Lilly and Company\u3068\u306e\u9593\u3067\u5275\u85ac\u306b\u95a2\u3059\u308b\u30e9\u30a4\u30bb\u30f3\u30b9\u304a\u3088\u3073\u5171\u540c\u7814\u7a76\u5951\u7d04\u3092\u7de0\u7d50\u3057\u307e\u3057\u305f\u3002<\/p>\n<p><a href=\"https:\/\/prismbiolab.com\/wp-content\/uploads\/2023\/11\/Lilly_PRISM_PR_Japanese-4529d0bc-ffcb-44dc-be34-16c9c30ea6ba.pdf\" target=\"_blank\" rel=\"noopener\">\u8a73\u7d30\u306f\u3053\u3061\u3089<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>TOKYO, Japan, 28 Nov 2023: \u2013PRISM BioLab, Co. Ltd. , a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a License and Collaboration Agreement with Eli Lilly and Company. Read Full Press Release<\/p>","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","tags":[],"news-category":[8],"class_list":["post-1924","news","type-news","status-publish","hentry","news-category-news","post"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target - PRISM BioLab<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prismbiolab.com\/ja\/news\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target - PRISM BioLab\" \/>\n<meta property=\"og:description\" content=\"TOKYO, Japan, 28 Nov 2023: \u2013PRISM BioLab, Co. Ltd. , a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a License and Collaboration Agreement with Eli Lilly and Company. Read Full Press Release\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prismbiolab.com\/ja\/news\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\/\" \/>\n<meta property=\"og:site_name\" content=\"PRISM BioLab\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-10T09:18:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prismbiolab.com\/wp-content\/uploads\/2024\/07\/career-collage.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1122\" \/>\n\t<meta property=\"og:image:height\" content=\"1097\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\\\/\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\\\/\",\"name\":\"PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target - PRISM BioLab\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#website\"},\"datePublished\":\"2023-11-29T01:00:45+00:00\",\"dateModified\":\"2024-04-10T09:18:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/prismbiolab.com\\\/news\\\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/prismbiolab.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/prismbiolab.com\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#website\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/\",\"name\":\"PRISM BioLab\",\"description\":\"PRISM BioLab MIMICS natural  peptides leading to cures of the  greatest health challenges\",\"publisher\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/prismbiolab.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#organization\",\"name\":\"PRISM BioLab\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/prism_logo_b.jpg\",\"contentUrl\":\"https:\\\/\\\/prismbiolab.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/prism_logo_b.jpg\",\"width\":300,\"height\":367,\"caption\":\"PRISM BioLab\"},\"image\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target - PRISM BioLab","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prismbiolab.com\/ja\/news\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\/","og_locale":"ja_JP","og_type":"article","og_title":"PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target - PRISM BioLab","og_description":"TOKYO, Japan, 28 Nov 2023: \u2013PRISM BioLab, Co. Ltd. , a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a License and Collaboration Agreement with Eli Lilly and Company. Read Full Press Release","og_url":"https:\/\/prismbiolab.com\/ja\/news\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\/","og_site_name":"PRISM BioLab","article_modified_time":"2024-04-10T09:18:55+00:00","og_image":[{"width":1122,"height":1097,"url":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2024\/07\/career-collage.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/prismbiolab.com\/news\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\/","url":"https:\/\/prismbiolab.com\/news\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\/","name":"PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target - PRISM BioLab","isPartOf":{"@id":"https:\/\/prismbiolab.com\/#website"},"datePublished":"2023-11-29T01:00:45+00:00","dateModified":"2024-04-10T09:18:55+00:00","breadcrumb":{"@id":"https:\/\/prismbiolab.com\/news\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prismbiolab.com\/news\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/prismbiolab.com\/news\/prism-biolab-and-lilly-enter-into-a-drug-discovery-collaboration-on-a-protein-protein-interaction-target\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/prismbiolab.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/prismbiolab.com\/news\/"},{"@type":"ListItem","position":3,"name":"PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target"}]},{"@type":"WebSite","@id":"https:\/\/prismbiolab.com\/#website","url":"https:\/\/prismbiolab.com\/","name":"PRISM BioLab","description":"PRISM BioLab MIMICS natural  peptides leading to cures of the  greatest health challenges","publisher":{"@id":"https:\/\/prismbiolab.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prismbiolab.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/prismbiolab.com\/#organization","name":"PRISM BioLab","url":"https:\/\/prismbiolab.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/prismbiolab.com\/#\/schema\/logo\/image\/","url":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2021\/09\/prism_logo_b.jpg","contentUrl":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2021\/09\/prism_logo_b.jpg","width":300,"height":367,"caption":"PRISM BioLab"},"image":{"@id":"https:\/\/prismbiolab.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news\/1924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/comments?post=1924"}],"version-history":[{"count":4,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news\/1924\/revisions"}],"predecessor-version":[{"id":2045,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news\/1924\/revisions\/2045"}],"wp:attachment":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/media?parent=1924"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/tags?post=1924"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/news-category?post=1924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}